• Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com

    المصدر: Buzz FX / 05 يناير 2025 02:41:14   America/New_York


    Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat January 5, 2025 Share Link copied to clipboard. StockNews.com assumed coverage on shares of Revance Therapeutics ( NASDAQ:RVNC - Get F
    Read more...
شارك على،